Author:
Praiss Aaron M.,Zhou Qin,Iasonos Alexia,Moukarzel Lea,Dessources Kimberly,Soldan Krysten,Su Katy,Sonoda Yukio,Roche Kara Long,Gardner Ginger J.,Troso-Sandoval Tiffany,Tew William P.,Grisham Rachel N.,Chi Dennis S.,O'Cearbhaill Roisin E.,Zivanovic Oliver
Funder
NCI
National Institutes of Health
Subject
Obstetrics and Gynecology,Oncology
Reference24 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022
2. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial;Shi;Lancet Oncol.,2021
3. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma;Chi;Cancer,2006
4. Randomized trial of Cytoreductive surgery for relapsed ovarian Cancer;Harter;N. Engl. J. Med.,2021
5. Secondary surgical Cytoreduction for recurrent ovarian Cancer;Coleman;N. Engl. J. Med.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献